Neuromodulation is a growing industry that promises to treat many disabling psychiatric (e.g., mood disorders) and other neurologic disorders (e.g., stroke). Given these claims, it is important to advocate for research to examine these assertions so that the best interests of patients
and the general public are protected. With this in mind, this review examines the current literature regarding three commonly used neuromodulation methods (cranial stimulation therapy (CES), transcranial direct current stimulation (tDCS), and transcranial magnetic therapy (TMS)), focusing
on magnetic resonance imaging (MRI) methods of assessing any therapeutic effects. Currently, the effort to validate these methods using state-of-the-art MRI methods is in its infancy though there are a growing number of studies that demonstrate objective MRI findings that illustrate therapeutic
effects. The possible benefits of using MRI to study the biological underpinnings of any neuromodulation effects, to improve delivery of treatment, and to further the science of neuromodulation are described along with suggestions for future research directions.
No Supplementary Data.
No Article Media
CRANIAL ELECTROTHERAPY STIMULATION;
DIRECT CURRENT STIMULATION;
TRANSCRANIAL MAGNETIC STIMULATION
Document Type: Research Article
May 1, 2016
More about this publication?
Technology and Innovation, edited and published by the National Academy of Inventors, is a forum for presenting information encompassing the entire field of applied sciences, with a focus on transformative technology and academic innovation. Regular features of T&I include commentaries contributed by the United States Patent and Trademark Office (USPTO) and in-depth profiles of Fellows of the National Academy of Inventors in every issue.